Meetings

John’s Top Recurring Meetings
Virtual meetings are easy to attend, but regular attendance at annual in-person events is the key to building your network and gaining deeper insight. My personal favorites for such in-person meetings are below. Of particular value for developers are BEAM’s AMR Conference and GAMRIC (formerly, the ESCMID-ASM conference series). Hope to see you there!

  • 1-3 Oct 2025 GAMRIC, the Global AMR Innovators Conference (Washington, DC). Formerly the ESCMID-ASM Joint Conference on Drug Development for AMR, this meeting series is being continued under the joint sponsorship of CARB-X, ESCMID, BEAM, GARDP, LifeArc, WHO, and AMR.Solutions. You can’t yet register for the 2025 meeting but please mark your calendar now and note that the meeting now runs 1-3 Oct (instead of 30 Sep-2 Oct). The ongoing series is expected to continue that successful format of prior meetings with a (mostly) single-track meeting. You can go here to see the initial details for the 2025 meeting (including a preliminary agenda) and go here to see details of the outstanding 2024 meeting. The abstract submission window will run 28 April to 13 June; an application round for travel grants is expected to run 16 April to 16 May.
  • 19-22 Oct 2025 (Georgia, USA): IDWeek 2025, the annual meeting of the Infectious Diseases Society of America. Details pending; go here for the general meeting website.
  • 3-4 Mar 2026 (Basel, Switzerland): The 10th AMR Conference. Sponsored by the BEAM Alliance, the 9th AMR Conference has just concluded and it’s again been an excellent meeting! Please mark your calendar for next year. You can’t register yet, but details will appear here
  • 17-21 April 2026 (Munich, Germany): ESCMID Global 2026, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. You can’t register yet, but you can go here for details on the outstanding 2025 meeting. 

  Upcoming meetings of interest to the AMR community:

  • 30 Apr 2025 (virtual, 10-5.15p ET): Presented by Sepsis Alliance, the Sepsis Alliance AMR Conference is 1-day virtual discussion of AMR- and sepsis-focused diagnostics, therapeutics, and advocacy. Go here for details and to register.
  • 19-23 June 2025 (Los Angeles): ASM Microbe, the annual meeting of the American Society for Microbiology. Go here for details.
  • 10-13 Sep 2026 (Lisbon, Portugal): 6th ESCMID Conference on Vaccines. Go here for details.
  • 1-3 Oct 2025 GAMRIC, the Global AMR Innovators Conference (Washington, DC; formerly the ESCMID-ASM Joint Conference on Drug Development for AMR). See list of Top Recurring meetings, above..
  • 11-19 Oct 2025 (Annecy, France, residential in-person program): ICARe (Interdisciplinary Course on Antibiotics and Resistance) … and 2025 will be the 9th year for this program. Patrice Courvalin orchestrates content with the support of an all-star scientific committee and faculty. The resulting soup-to-nuts training covers all aspects of antimicrobials, is very intense, and routinely gets rave reviews! Seating is limited, so mark your calendars now if you are interested. Applications should open ~March 2025 — go here for more details.
  • 19-22 Oct 2025 (Georgia, USA): IDWeek 2025. See list of Top Recurring meetings, above.
  • 3-4 Mar 2026 (Basel, Switzerland): The 10th AMR Conference sponsored by the BEAM Alliance. See list of Top Recurring meetings, above.
  • 8-13 Mar 2026 (Renaissance Tuscany Il Ciocco, Italy): 2026 Gordon Research Conference (GRC) entitled “Antibacterials of Tomorrow to Combat the Global Threat of Antimicrobial Resistance.” A Gordon Research Seminar (GRS) will be held the weekend before (7-8 Mar) for young doctoral and post-doctoral researchers. Space for the GRS and the GRC is limited; for details and to apply, go here for the GRC and here for the GRS.
  • 17-21 April 2026 (Munich, Germany): ESCMID Global 2026, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. See Recurring Meetings list, above.

Self-paced courses, online training materials, and other reference materials:

Last updated on

Share

Manufacturing underpins access in LMICs: An update on cefiderocol

Dear All, No one is safe until we’re all safe! In the 7 April 2025 newsletter on antibiotic access (“UNSLAP: You reach for the antibiotic … and it’s not there!”), Louise Norton-Smith and I concluded that we need to work to address all the elements of the long and delicate supply chain from manufacturing to local

Most current global summary of Pull incentives

Dear All, I was recently asked about a ready summary of the current state of play of Pull incentives around the globe. In response, here are two related resources: First, WHO and the Global AMR R&D Hub jointly author an update on the state of incentives for R&D. Their most current report is dated 14 Oct

Sign-on letter encouraging AMR funding in the FY2026 US budget

Dear All, If you represent a US-based organization with an interest in AMR, there is an opportunity to sign a letter advocating for AMR-related funding in the FY2026 US Government (USG) budget. Founded in 2014, IDSA’s S-FAR (Stakeholder Forum on Antimicrobial Resistance) has been steadily coordinating messages to the USG from professional groups with an interest

UNSLAP: You reach for the antibiotic … and it’s not there!

Dear All (with thanks to Louise for co-authoring and with a wonkish alert … settle in for the ride!), Today’s newsletter discusses the intersection of three themes around antibiotic access. Recall first how the paper by Baraldi et al. (1 Dec 2024 newsletter) taught us that there are at least six variations to the idea

Scroll to Top